---
title: "Core technical staff of OBiO Tech, Wei Houliang, has left the company"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/232065899.md"
description: "According to the Zhitong Finance APP, OBiO Tech announced that Mr. Wei Houliang, the director of the CDMO Technical Support Department, has resigned for personal reasons. After his departure, he will no longer hold any position in the company, and the company will no longer recognize Mr. Wei Houliang as a core technical personnel. The company has newly recognized Ms. Liu Suli as a core technical personnel"
datetime: "2025-03-17T10:02:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/232065899.md)
  - [en](https://longbridge.com/en/news/232065899.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/232065899.md)
generator: "portal-rs"
---

# Core technical staff of OBiO Tech, Wei Houliang, has left the company

According to the Zhitong Finance APP, OBiO Tech (688238.SH) announced that Mr. Wei Houliang, the director of the CDMO technical support department, resigned for personal reasons. After his departure, he will no longer hold any position in the company, and the company will no longer recognize Mr. Wei Houliang as a core technical personnel. The company has newly recognized Ms. Liu Suli as a core technical personnel

### Related Stocks

- [688238.CN](https://longbridge.com/en/quote/688238.CN.md)

## Related News & Research

- [A: Q3 results exceeded expectations with strong growth in pharma, CDMO, and China, driving raised FY26 guidance](https://longbridge.com/en/news/297095880.md)
- [Thor Medical COO Ellingsaeter shifts to dedicated operations role, CFO search starts](https://longbridge.com/en/news/296861027.md)
- [Famar names Mara Candido chief commercial officer](https://longbridge.com/en/news/297053815.md)
- [Scinai Immunotherapeutics: Expanded CDMO platform drives growth, but operating losses persist as revenue scales](https://longbridge.com/en/news/297069758.md)
- [Transcenta Holding announces extraordinary general meeting](https://longbridge.com/en/news/296833106.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**